SymBio Pharmaceuticals Limited (TYO:4582)

SymBio Pharmaceuticals Revenue

SymBio Pharmaceuticals had revenue of 233.46M JPY in the quarter ending March 31, 2026, a decrease of -11.57%. This brings the company's revenue in the last twelve months to 1.28B, down -39.73% year-over-year. In the year 2025, SymBio Pharmaceuticals had annual revenue of 1.31B, down -46.70%.

• Revenue (ttm): 1.28B
• Revenue Growth: -39.73%
• P/S Ratio: 4.41
• Revenue / Employee: 14.03M
• Employees: 91
• Market Cap: 5.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.31B	-1.15B	-46.70%
Dec 31, 2024	2.45B	-3.14B	-56.13%
Dec 31, 2023	5.59B	-4.42B	-44.15%
Dec 31, 2022	10.01B	1.75B	21.21%
Dec 31, 2021	8.26B	5.27B	176.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error